­
­
­
­

Inventi Impact: Oncology

Articles

  • Inventi:hoc/33073/20
    Low Advanced Lung Cancer Inflammation Index Predicts Poor Prognosis in Locally Advanced Nasopharyngeal Carcinoma Patients Treated with Definitive Concurrent Chemoradiotherapy
    Research 2021 : January - March
    Erkan Topkan, Yurday Ozdemir, Ahmet Kucuk, Ozan Cem Guler, Ahmet Sezer, Ali Ayberk Besen, Huseyin Mertsoylu, Sukran Senyurek, Nulifer Kilic Durankus, Yasemin Bolukbasi, Ugur Selek, Berrin Pehlivan

    Purpose. We aimed to retrospectively investigate the prognostic worth of pretreatment advanced lung cancer inflammation index\n(ALI) in locally advanced nasopharyngeal carcinoma (LA-NPC) patients treated with concurrent chemoradiotherapy (C-CRT).\nPatients and Methods. A total of 164 LA-NPC patients treated with cisplatinum-based definitive C-CRT were included in this\nretrospective cohort analysis. The convenience of ideal pre-C-CRT ALI cut-offs affecting survival results was searched by employing\nthe receiver operating characteristic (ROC) curve analyses. The primary endpoint was the link between the ALI groups and overall\nsurvival (OS), while cancer-specific survival (CSS), locoregional progression-free survival [LR(PFS)], distant metastasis-free survival\n(DMFS), and PFS comprised the secondary endpoints. Results.The ROC curve analyses distinguished a rounded ALI cut-off score of\n24.2 that arranged the patients into two cohorts.........................

    How to Cite this Article
    Attribution/ CC Compliant Citation: Topkan, Erkan, et al.\n\"Low Advanced Lung Cancer Inflammation Index Predicts\nPoor Prognosis in Locally Advanced Nasopharyngeal\nCarcinoma Patients Treated with Definitive Concurrent\nChemoradiotherapy.\" Journal of Oncology 2020 (2020).\nhttps://doi.org/10.1155/2020/3127275\nhttp://creativecommons.org/licenses/by/4.0/\nSome formatting elements, header, footer, logos, dates and\npagination were modified while adapting this article.
    Download Full Text